Retail News CRM

Tag: spearheading

  • Shinsegae Chairman Elevates to CEO Role, Spearheading Growth for E-Mart & Property Division

    Shinsegae Chairman Elevates to CEO Role, Spearheading Growth for E-Mart & Property Division

    Shinsegae Group’s chairman, Chung Yong-jin, is set to expand his role within the organization, assuming CEO positions at both E-mart and Shinsegae Property. This move by the South Korean retail heavyweight signals an aggressive push for growth in its primary sectors.

    Shifting Responsibility and Strategy

    Chung’s dual appointment marks a significant shift within the group, with the chairman now directly overseeing the operations of the nation’s largest retailer and its property development subsidiary. This decision comes at a crucial time when the company, faced with a challenging retail environment, is actively seeking new avenues for expansion. The decision underscores Chung’s resolve to shoulder a larger part of the company’s overall direction and performance.

    Chung appreciates the market’s expectations for clear accountability in the company’s management. As the newly appointed CEO, he is prepared to submit to the evaluation of the board of directors and shareholders.

    In his capacity at E-Mart, Chung will directly oversee the retailer’s operations and future growth strategies. The company believes this change mirrors his dedication to tackling current business hurdles and boosting shareholder value.

    Leadership Changes and Future Plans

    In his role at Shinsegae Property, Chung will supervise the group’s major development projects and support plans to secure locations for a proposed AI data centre that was announced earlier this year.

    This management shakeup follows a recent controversy at Starbucks Korea, where E-Mart is the majority shareholder. Since this incident, the retailer has committed to organizational reforms to bolster governance and operational supervision.

    Shinsegae Property executive Lee Hyung-cheon has been named as co-CEO and will continue to oversee the company’s regular operations and development activities. Shin Dong-woo has been nominated as the new CEO for Starbucks Korea. Shinsegae has stated that he will focus on reinforcing internal controls, enhancing operational systems, and restoring trust among clients and partners.

    Questions & Answers

    What new roles is Chung Yong-jin assuming at Shinsegae Group?
    Chung Yong-jin is taking on the dual roles of CEO at both E-mart and Shinsegae Property.

    What implications does this dual appointment have for the company?
    This move signals a significant shift in Shinsegae Group’s strategy, with Chung Yong-jin assuming more responsibility for the company’s overall performance and direction. It also demonstrates a commitment to tackling current business challenges and enhancing shareholder value.

    How will the roles be distributed among the leadership after these changes?
    Chung Yong-jin will oversee operations and future growth strategies at E-Mart and major development projects at Shinsegae Property. Lee Hyung-cheon will continue to oversee day-to-day operations and development activities at Shinsegae Property as co-CEO. Shin Dong-woo will focus on internal controls, operational systems and regaining trust as the CEO of Starbucks Korea.

  • Manulife Singapore Pioneers Multi-Cancer Screening for Insured, Spearheading Preventive Healthcare Revolution

    Manulife Singapore Pioneers Multi-Cancer Screening for Insured, Spearheading Preventive Healthcare Revolution

    Manulife Singapore is intensifying its commitment to preventative healthcare and lifespan enhancement solutions via a new partnership with Guardant Health, a precision oncology expert. This strategy makes Manulife the pioneer insurance firm in Singapore to provide the Shield™ multi-cancer detection (MCD) blood test, available to eligible customers from May 2026.

    This collaboration is part of a broader Asian alliance between the two companies, covering Singapore, Hong Kong, and the Philippines. The partnership reiterates Manulife’s overarching strategy of amalgamating health protection with long-term wealth and lifespan planning.

    Emphasizing Proactive Detection

    Designed to screen ten prevalent cancers with a single blood draw, the Shield™ MCD lab-crafted test underscores several cancers with high fatality rates in Singapore. The test was recently awarded the “Oncology Product Innovation of the Year” title at the Healthcare Asia Medtech Awards and received the Breakthrough Device Designation by the US Food and Drug Administration (FDA).

    This partnership advances the pre-existing relationship between Manulife and Guardant Health, as the latter already offers the Guardant360® Liquid test for advanced solid tumours to customers in Singapore.

    Longevity as a Focal Point

    The partnership evidences an increasing emphasis on preventative care and healthy ageing among insurers as Asia’s populace demographic shift. “As longevity increases, the primary concern is the quality of those extended years,” stated Benoit Meslet, President and CEO of Manulife Singapore. “Providing customers with early insights into their health enables them to make informed decisions today for a healthier tomorrow.”

    Singapore is one of the fastest-ageing societies in Asia, with healthcare systems prioritising preventative and personalised care. In 2024, cancer was the predominant cause of death in Singapore, accounting for over a quarter of all fatalities.

    Manulife’s initiative aligns with the findings from the 2025 Asia Care Survey, showing that over half of Singapore consumers perceive cancer as the hardest illness to prevent.

    Questions & Answers

    What is the new collaboration between Manulife Singapore and Guardant Health about?

    The collaboration aims to offer the Shield™ multi-cancer detection (MCD) blood test to eligible Manulife customers in Singapore, aiding in the early detection of ten common cancers.

    How does this partnership align with Manulife’s broader strategy?

    This partnership coincides with Manulife’s broader strategy of blending health protection with long-term wealth and lifespan planning. It underscores the insurer’s emphasis on preventative care and healthy ageing.

    What insights does the 2025 Asia Care Survey provide?

    The survey reveals that over half of Singapore consumers consider cancer as the most difficult disease to prevent, indicating the importance of early detection and preventative healthcare.